PADCEV Patient Assistance Program
The PADCEV Patient Assistance Programa (PAP) provides PADCEV® (enfortumab vedotin-ejfv) at no cost to uninsured patients who meet the program eligibility requirements.
PADCEV Support Solutions will evaluate a patient's eligibility for the PAP program.
For more information, contact us at 1‑888‑402‑0627. We are available Monday–Friday, 8:30 am–8:00 pm ET.
Your patient may be eligible for the PAP program if he or she:
- Does not have insurance or has insurance that excludes coverage for PADCEV,a
- Has a verifiable shipping address in the United States,
- Has been prescribed PADCEV for an FDA-approved indication, AND
- Meets the program financial eligibility requirements
Please contact PADCEV Support Solutions at 1-888-402-0627 to obtain a copy of the PAP Application. Please fully complete the PAP Application, including all signatures. You can either upload it through the Prescriber Portal or fax it to 1-877-747-6843. If the patient is eligible for the PAP Program, we will notify you and the patient.
PADCEV Support Solutions is a component of Astellas Pharma Support SolutionsSM.
aProgram subject to eligibility restrictions and program terms and conditions.
PADCEV® and the PADCEV device are trademarks jointly owned by Agensys, Inc., and Seagen Inc.